Page 41 - Robert Kramer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UNITED NATIONS -- The U.N. Security Council is calling for accelerated availability of...

skodonnell/iStock (WASHINGTON) -- The beleaguered biotech firm Emergent BioSolutions will face a congressional inquiry Wednesday, scrutinized for what investigators say are the "serious deficiencies" in their manufacturing that led to up to 15 million doses' worth of COVID-19 vaccine ingredients being compromised and disposed of because of cross-contamination. Top Emergent executives Fuad El-Hibri, the company's founder and executive chairman, and Robert Kramer, its chief executive officer, will appear on Capi...

1 of 40 A woman takes selfie as she receives the Covishield vaccine against COVID-19 in Gauhati, Assam, India, Monday, May 17, 2021. Anupam Nath A heath worker in protective suit takes nasal swab sample of a man to test for COVID-19 in a slum area in Gauhati, Assam state, India, Monday, May 17, 2021. Anupam Nath People stand in queue to receive the Covishield vaccine against COVID-19 in Gauhati, Assam, India, Monday, May 17, 2021. Anupam Nath FILE - In this May 10, 2021, file photo, health workers and volunteers in personal protectiv...

COVID deaths, cases have fallen in US Updated May 12, 2021, 1 hour ago Email to a Friend COVID-19 deaths in the United States have tumbled to an average of around 600 per day — the lowest level in 10 months — with the number of lives lost dropping to single digits in well over half the states and hitting zero on some days. Confirmed infections, meanwhile, have fallen to about 38,000 day on average, their lowest mark since mid-September. While that is still cause for concern, they have plummeted 85 percent from a peak of more than a quarter-million cases per day in early January. Th...

© Getty Images Leaders at Emergent BioSolutions, the manufacturer whose Baltimore factory ruined millions of COVID-19 vaccine doses, are slated to testify in front of the House next week as part of an inquiry into the company.  The company’s CEO and President Robert Kramer and Executive Chairman Fuad El-Hibri agreed to appear before the Oversight and Reform Subcommittee on the Coronavirus Crisis on May 19 to address questions about the up to 15 million destroyed doses of the Johnson & Johnson coronavirus vaccine.  The subcommittee, chaired by House Majority Whip James Clyburn (D-S.C.), s...